Pathological analyses of early recurrence and malignant transformation in meningiomas.

被引:21
作者
Arai H. [1 ]
Beppu T. [1 ]
Wada T. [1 ]
Yoshida Y. [1 ]
Kubo Y. [1 ]
Suzuki M. [1 ]
Ogawa A. [1 ]
机构
[1] Department of Neurosurgery, Iwate Medical University, School of Medicine
关键词
Meningioma; MIB-1; p53 protein; Flow cytometry (FCM); Fluorescence in situ hybridization (FISH);
D O I
10.1007/BF02482099
中图分类号
学科分类号
摘要
We investigated factors of the early recurrence and malignant transformation of histologically benign meningiomas using immunohistochemistry for MIB-1 positive indices (PI) and p53 protein expression, a flow cytometric DNA analysis, and the examination of numerical chromosomal aberrations detected by fluorescence in situ hybridization using an alpha-satellite DNA probe and a bcr gene locus-specific probe. Twenty-six meningiomas of 23 patients were classified into two groups: the 3 patients in whom a recurrence was defined within two years after initial surgery and who showed histologically malignant features were classified as the early recurrent group, and the other 20 patients in whom recurrence did not develop during the same period were classified as the nonrecurrent group. DNA aneuploidy was observed in 40% of the nonrecurrent patients and in 67% of the early recurrent patients. Loss of chromosome 22 was the most common numerical aberration, but the aberrations characteristic of early recurrent meningiomas were not detected. The MIB-1 PI values of the early recurrent meningiomas were higher than those of nonrecurrent meningiomas, suggesting that MIB-1 PI is very important for biological and histopathological analyses and prediction of the future recurrence of meningiomas.
引用
收藏
页码:37 / 40
页数:3
相关论文
共 58 条
[1]  
Kleihuse P(1993)The new WHO classification of brain tumors Brain Pathol 3 255-269
[2]  
Burger PC(1983)The recurrence of intracranial meningiomas after surgical treatment J Neurosurg 58 51-56
[3]  
Scheithauer BW(1985)Meningiomas: analysis of recurrence and progression following neurosurgical resection J Neurosurg 62 18-24
[4]  
Adegbite AB(1992)Clinical application of flow cytometry for DNA analysis of solid tumors Acta Pathol Jpn 42 1-14
[5]  
Khan MI(1992)Application of fluorescence in situ hybridization to detection of chromosomal aberrations Cytom Res 2 1-11
[6]  
Paine KWE(1983)Flow cytometry in clinical cancer research Cancer Res 43 982-997
[7]  
Mirimanoff RO(1990)Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors Cancer 65 1194-1205
[8]  
Dosoretz DE(1989)Deoxyribonucleic acid flow cytometry of benign prostatic disease J Urol 142 759-762
[9]  
Linggood RM(1988)A comparative study of DNA cytometry methods for benign and malignant thyroid tissue Am J Clin Pathol 89 760-763
[10]  
Sasaki K(1980)Correlations between clinical and cytogenetical data in 180 human meningiomas Cancer Genet Cytogenet 1 351-356